DMRE Fundamental Analysis - DEMIRE DT MTS REAL ESTATE AG

Fundamental Rating

Taking everything into account, DMRE scores 2 out of 10 in our fundamental rating. DMRE was compared to 70 industry peers in the Real Estate Management & Development industry. DMRE may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, DMRE is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

DMRE had negative earnings in the past year.

In the past year DMRE had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: DMRE reported negative net income in multiple years.

Of the past 5 years DMRE 4 years had a positive operating cash flow.

1.2 Ratios

DMRE has a worse Return On Assets (-10.33%) than 80.00% of its industry peers.

The Return On Equity of DMRE (-48.04%) is worse than 80.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-10.33%
ROE	-48.04%
ROIC	N/A

ROA(3y)-8.15%

ROA(5y)-4.1%

ROE(3y)-34.25%

ROE(5y)-18.11%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 57.08%, DMRE perfoms like the industry average, outperforming 52.86% of the companies in the same industry.

In the last couple of years the Gross Margin of DMRE has declined.

The Profit Margin and Operating Margin are not available for DMRE so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	57.08%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.01%

GM growth 5Y-2.77%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DMRE does not have a ROIC to compare to the WACC, probably because it is not profitable.

DMRE has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, DMRE has less shares outstanding

The debt/assets ratio for DMRE has been reduced compared to a year ago.

2.2 Solvency

DMRE has an Altman-Z score of 0.11. This is a bad value and indicates that DMRE is not financially healthy and even has some risk of bankruptcy.

DMRE has a worse Altman-Z score (0.11) than 78.57% of its industry peers.

DMRE has a debt to FCF ratio of 25.03. This is a negative value and a sign of low solvency as DMRE would need 25.03 years to pay back of all of its debts.

Looking at the Debt to FCF ratio, with a value of 25.03, DMRE is in line with its industry, outperforming 55.71% of the companies in the same industry.

A Debt/Equity ratio of 2.16 is on the high side and indicates that DMRE has dependencies on debt financing.

DMRE has a worse Debt to Equity ratio (2.16) than 81.43% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.16
Debt/FCF	25.03
Altman-Z	0.11

ROIC/WACCN/A

WACC3.54%

2.3 Liquidity

A Current Ratio of 0.61 indicates that DMRE may have some problems paying its short term obligations.

DMRE's Current ratio of 0.61 is on the low side compared to the rest of the industry. DMRE is outperformed by 74.29% of its industry peers.

DMRE has a Quick Ratio of 0.61. This is a bad value and indicates that DMRE is not financially healthy enough and could expect problems in meeting its short term obligations.

DMRE has a worse Quick ratio (0.61) than 60.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.61
Quick Ratio	0.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.27% over the past year.

Looking at the last year, DMRE shows a very negative growth in Revenue. The Revenue has decreased by -23.73% in the last year.

The Revenue has been decreasing by -4.11% on average over the past years.

EPS 1Y (TTM)27.27%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-233.64%

Revenue 1Y (TTM)-23.73%

Revenue growth 3Y-7.1%

Revenue growth 5Y-4.11%

Sales Q2Q%-27.75%

3.2 Future

DMRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.51% yearly.

Based on estimates for the next years, DMRE will show a quite strong growth in Revenue. The Revenue will grow by 13.73% on average per year.

EPS Next Y83.33%

EPS Next 2Y34.63%

EPS Next 3Y20.51%

EPS Next 5YN/A

Revenue Next Year99.39%

Revenue Next 2Y22.6%

Revenue Next 3Y13.73%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DMRE. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DMRE. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

DMRE's Enterprise Value to EBITDA is on the same level as the industry average.

Based on the Price/Free Cash Flow ratio, DMRE is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	3.62
EV/EBITDA	23.31

4.3 Compensation for Growth

DMRE's earnings are expected to grow with 20.51% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y34.63%

EPS Next 3Y20.51%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

DMRE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DEMIRE DT MTS REAL ESTATE AG

FRA:DMRE (7/4/2025, 7:00:00 PM)

0.705

+0.03 (+4.44%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)05-26 2025-05-26

Earnings (Next)08-14 2025-08-14

Inst Owners0.77%

Inst Owner ChangeN/A

Ins Owners0%

Ins Owner ChangeN/A

Market Cap75.98M

Analysts40

Price Target0.67 (-4.96%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-5.71%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-300%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)106.27%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.01
P/FCF	3.62
P/OCF	2.35
P/B	0.38
P/tB	0.38
EV/EBITDA	23.31

EPS(TTM)-0.92

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)0.19

FCFY27.6%

OCF(TTM)0.3

OCFY42.6%

SpS0.7

BVpS1.88

TBVpS1.88

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-10.33%
ROE	-48.04%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	57.08%
FCFM	27.95%

ROA(3y)-8.15%

ROA(5y)-4.1%

ROE(3y)-34.25%

ROE(5y)-18.11%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-5.01%

GM growth 5Y-2.77%

F-Score4

Asset Turnover0.08

Health

		Industry Rank	Sector Rank
Debt/Equity	2.16
Debt/FCF	25.03
Debt/EBITDA	19.89
Cap/Depr	21.68%
Cap/Sales	15.2%
Interest Coverage	N/A
Cash Conversion	147.09%
Profit Quality	N/A
Current Ratio	0.61
Quick Ratio	0.61
Altman-Z	0.11

F-Score4

WACC3.54%

ROIC/WACCN/A

Cap/Depr(3y)135.54%

Cap/Depr(5y)384.35%

Cap/Sales(3y)19.79%

Cap/Sales(5y)28.72%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)27.27%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-233.64%

EPS Next Y83.33%

EPS Next 2Y34.63%

EPS Next 3Y20.51%

EPS Next 5YN/A

Revenue 1Y (TTM)-23.73%

Revenue growth 3Y-7.1%

Revenue growth 5Y-4.11%

Sales Q2Q%-27.75%

Revenue Next Year99.39%

Revenue Next 2Y22.6%

Revenue Next 3Y13.73%

Revenue Next 5YN/A

EBIT growth 1Y-1806.92%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year151.55%

EBIT Next 3Y35.87%

EBIT Next 5YN/A

FCF growth 1Y-24.18%

FCF growth 3Y-20.3%

FCF growth 5YN/A

OCF growth 1Y-39.94%

OCF growth 3Y-19.11%

OCF growth 5Y-5.51%

DEMIRE DT MTS REAL ESTATE AG (DMRE.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens